Retired Compendial Notices: 2010-2014

<1> Injections, Labeling of Ferrules and Cap Overseals Section (posted 04–Aug–2010)
<1> Injections and <788> Particulate Matter in Injections (posted 26–Aug–2011)
<1> Injections, Labeling of Ferrules and Cap Overseals Section (posted 4–Aug–2010)
<3> USP Has Revised New General Chapter <3> Topical and Transdermal Drug Products: Quality Tests; To Be Republished in PF 36(6) (posted 20–Sep–2010)
<7> Labeling (posted 29–Dec–2011)
<17> USP Seeks Comments on Proposed General Chapter <17> Prescription Container Labeling (posted 03–Jan–2011)
<17> Recommendations on Prescription Container Labeling (posted 26–Apr–2010)
<41> Balances (posted 25–Oct–2013)
<81> Antibiotics—Microbial Assays: USP Proposes Revisions in PF 365 (posted 27–Aug–2010)
<232> Elemental Impurities—Limits (posted 27–Apr–2012; updated 21–Nov–2012)
<233> Elemental Impurities—Procedures (posted 27–Apr–2012; updated 21–Nov–2012)
<232> Elemental Impurities—Limits and <233> Elemental Impurities—Procedures Revision Bulletin (posted 28–Jan–2013)
<561> Articles of Botanical Origin (posted 27–Jun–2014)
<659> Packaging and Storage Requirements (posted 27–Apr–2012; updated 21–Nov–2012)
<797> Pharmaceutical Compounding—Sterile Preparations (posted 27–Dec–2013)
<823> Radiopharmaceuticals for Positron Emission Tomography–Compound: Notice of Intent to Revise (posted 24–Nov–2010)
<1066> Physical Environments that Promote Safe Medication Use: Notice of Intent to Revise (posted 30–Apr–2010)
<1083> Good Distribution Practices—Supply Chain Integrity Posted for Comment, Workshop Scheduled (posted 29–Dec–2011)
<1092> The Dissolution Procedure: Development and Validation, Proposed Revisions and Stimuli Article (posted 22–Nov–2013)
<1121> Stimuli Article and Proposed Revisions (posted 29–Dec–2011)
<1121> Nomenclature: Monograph Naming Policy for Salt Drug Substances in Drug Products and Compounded Preparations (posted 04–Jun–2007; official 01–May–2013)
<1160> Pharmaceutical Calculations in Prescription Compounding (posted 25–Apr–2014)
<1660> Evaluation of the Inner Surface Durability of Glass Containers Posted for Comment (posted 27–Apr–2012)
<2232> Elemental Contaminants in Dietary Supplements (posted 27–Apr–2012)
Implementation Deferred for General Chapters <232> Elemental Impurities—Limits and <233> Elemental Impurities—Procedures (posted 24–May–2013)
Acetaminophen (posted 26–Jul–2013)
Admission Criteria and Safety Classification for Dietary Supplements Guideline Update (posted 18–Oct–2012)
Additional Feedback Sought on Proposed Storage and Distribution General Chapters (posted 13–Jun–2014)
Aluminum Sulfate and Calcium Acetate for Topical Solution (posted 31–Oct–2014)
Amoxicillin and Clavulanate Potassium for Oral Suspension: Notice of Intent to Revise (posted 23–Nov–2011)
Amoxicillin (posted 19–Dec–2014)
Ampicillin (posted 01–Nov–2011)
Atorvastatin Calcium (posted 25–Feb–2011)
Benzalkonium Chloride and Benzalkonium Chloride Solution (posted 29–Dec–2011)
Calcitonin Salmon Injection and Calcitonin Salmon Nasal Spray (posted 01–Oct–2013)
Calcitonin Salmon Monographs (posted 28–Oct–2011)
Carbidopa (posted 29–Dec–2011)
Cefazolin Injection (posted 25–Apr–2014)
Cefdinir for Oral Suspension (posted 27–Dec–2013)
Cefdinir Capsules (posted 27–Dec–2013)
Ceftriaxone Injection (posted 25–Apr–2014)
Cephalexin Monographs (posted 07–Dec–2009; revised 30–Jun–2010)
Change to General Chapters Reference to Preservation, Packaging, Storage and Labeling Section of General Notices (posted 18–May–2012)
Chlorhexidine Acetate (11–Mar–2014)
Chlorhexidine Gluconate Solution (11–Mar–2014)
Chlorhexidine Hydrochloride (11–Mar–2014)
Colloidal Oatmeal (posted 27–Apr–2012)
Complete Reagent Section No Longer Being Printed in Supplements to USP–NF (posted 01–Feb–2013)
Compounded Preparations Title Change (posted 29–Aug–2014)
Container Content Reference Corrections in Monographs and General Chapter (posted 27–Jan–2012)
Copovidone (posted 09–Aug–2011)
Correction to Pharmacopeial Forum 39(1): General Chapter <601> Aerosols, Nasal Sprays, Metered-Dose Inhalers, and Dry Powder Inhalers (posted 18–Jul–2013)
Correction to Pharmacopeial Forum 39(1): Benzethonium Chloride (posted 20–Mar–2013)
Correction to PF 39(4): Gabapentin (posted 31–Jul–2013)
Errata Posting Schedule Revised (posted 14–Sep–2012)
Errata Tables Corrected (posted 22–Feb–2013)
Esmolol Hydrochloride (posted 28–Dec–2012)
Ethylcellulose (posted 01–Mar–2011)
First Prescription/Nonprescription Stakeholder Forum for 2010–2015 Cycle Enables Broader Participation (posted 08–October–2010)
First Excipients Stakeholder Forum Scheduled for June (posted 22–Mar–2013)
First Supplement to USP 37–NF 32 Online and USB Flash Drive Correction
Ganoderma Lucidum Fruiting Body (27–Jun–2014)
Ganoderma Lucidum Fruiting Body Powder (27–Jun–2014)
General Chapter <911> Viscosity Reference Corrections in Monographs (posted 31–May–2012)
General Notices 6.50.20 Solutions Erratum (posted 25–Jul–2014)
General Notices (posted 27–Apr–2012)
General Notices and Requirements: Proposed Revisions to be Published for Comment in PF (posted 05–Dec–2014)
Proposed Revisions to the General Notices and Requirements Published for Comment in Pharmacopeial Forum 39(1) [Jan.–Feb. 2013] (posted 28–Dec–2012; updated 04–Feb–2013)
Glacial Acetic Acid (posted 26–Mar–2010)
Glycopyrrolate (posted 24–Feb–2012)
Heparin Sodium Monograph Comment Period Extended (posted 30–Nov–2012)
Heparin Lock Flush Solution (posted 29–Jun–2012)
Heparin Sodium Injection: Notice of Intent to Revise (posted 24–Feb–2012)
High Fructose Corn Syrup: Notice of Intent to Revise (posted 26–Oct–2012)
Introduction to a General Chapter for Veterinary Products Posted For Comment, Workshop Scheduled (posted 22–May–2012)
Levelbuterol Hydrochloride (posted 29–Jul–2011)
Levelbuterol Inhalation Solution (posted 29–Jul–2011)
Levalbuterol Inhalation Solution (posted 07–Feb–2014; updated 25–Apr–2014)
List of Revised Titles in the Description and Solubility Reference Table of USP 36–NF31 2S (posted 03–Jun–2013)
Loperamide Hydrochloride Oral Solution (posted 01–Oct–2013)
Loratadine Oral Solution: Notice of Intent to Revise (posted 29–Oct–2010)
Methylpyrrolidone: Notice of Intent to Revise (posted 01–Aug–2012)
Mirtazapine Tablets (posted 29–Jul–2011)
Monographs and GC Affected by Revisions to GC <231> Heavy Metals (25–Jul–2014; updated 31–Jul–2014)
Nominations Being Accepted for the USP 2013 Awards Program (posted 26–Apr–2013)
Norethindrone Acetate and Ethinyl Estradiol Tablets: Notice of Intent to Revise (posted 30–Jul–2010)
Olanzapine Tablets (posted 27–May–2011)
Omega-3-Acid Ethyl Esters (posted 30–May–2014; updated 27–Feb–2015)
Online Enhancements to Help Users Access USP–NF New Official Text (posted 26–Oct–2012)
Orlistat (posted 22–Mar–2013)
Oxycodone Hydrochloride: Notice of Intent to Revise (POSTPONEMENT) (posted 24–Sep–2010)
Pharmacopeial Forum Transitions to a Free, Online Resource in January 2011 (posted 8–Sep–2010)
PF 37(6) Posting (posted 18–Nov–2011)
Polymyxin B Sulfate (posted 28–Feb–2014)
Polysorbate 20 (posted 27–Dec–2013)
Prescription/Nonprescription Stakeholder Forum Date Announced (posted 06–Apr–2011)
Prescription/Nonprescription Stakeholder Forum Scheduled (posted 24–Feb–2012)
Prescription/Nonprescription Stakeholder Forum Scheduled for June; Agenda Topics Sought (posted 31–Jan–2013; deadline 30–Apr–2013)
Propofol Injectable Emulsion: Notice of Intent to Revise (posted 28–Jan–2011)
Protamine Sulfate Monographs (posted 26–Feb–2010)
Publication Announcements for USP 37–NF 32 1S: General Chapter Format and Reagent PDFs (posted 31–Jan–2014)
Reagent PDFs and Errata PDFs Online for USP 36–NF 31 2S (posted 31–May–2013)
Revision Bulletins to be Posted Bimonthly (posted 31–Aug–2012)
Revision to USP Pending Monographs Guideline (posted 30–Apr–2010)
Revision to USP Pending Monographs Guideline (posted 30–Jul–2010)
Revision to USP Pending Monographs Guideline (posted 23–Nov–2011)
Searchable Errata Database Launches (posted 30–Nov–2012)
Sesame Oil (posted 31–Oct–2014)
Sertraline Tablets (posted 26–Aug–2011)
Simethicone Emulsion: Notice of Intent to Revise (posted 27–Apr–2012)
Stimuli Article on Lifecycle Management of Analytical Procedures Posted for Comment (posted 26–Jul–2013)
Tacrolimus (posted 27–Jun–2014)
Tacrolimus Capsules (posted 25–Oct–2013)
Tamsulosin Hydrochloride Capsules: Notice of Intent to Revise (posted 30–Apr–2010)
Tazobactam: Notice of Intent to Revise (posted 28–Jan–2011)
Tramadol Hydrochloride: Notice of Intent to Revise (posted 29–Jun–2012)
Travoprost Ophthalmic Solution (posted 25–Feb–2011)
Updates to Chemical Information Section of USP–NF Monographs (posted 27–Dec–2013)
USP 34–NF 29 December Errata Posting (posted 30–Dec–2010)
USP 36–NF 31 Flash Drive Information (posted 11–Mar–2013)
USP to Host Veterinary Medicines Events in November 2012, in Rockville, MD (posted 22–May–2012)
USP Monograph Modernization Initiative (posted 08–Feb–2011)
USP Public Statement on Completion of Evaluations of Recall of USP 33–NF 28 (posted 04–Oct–2010)
USP Seeking Public Participation in Organic Impurities Survey (posted 26–Apr–2013)
USP Seeking Public Participation in Residual Solvent Testing Survey (posted 26–Apr–2013)
USP Seeks Submission of Proposals for Monograph Modernization (posted 28–May–2010)
Vasopressin: Notice of Intent to Revise (posted 31–Mar–2011)
Valacyclovir Hydrochloride (posted 30–Jun–2011)
Vincristine Sulfate Monographs–USP Seeks Advice on Official Date: Notice of Intent to Revise (posted 30–Apr–2010)